5 High Growth Micro-Cap Stocks to Buy According to Hedge Funds

4. CVRx, Inc. (NASDAQ:CVRX)

Quarterly Revenue Growth YoY as of December 31, 2022: 96.17%

Number of Hedge Fund Holders: 10

CVRx, Inc. (NASDAQ:CVRX) is a commercial-stage medical device company, headquartered in Minneapolis, Minnesota. The company is involved in the design and development of neuromodulation solutions for patients with cardiovascular diseases. As of February 23, CVRx, Inc. (NASDAQ:CVRX) has returned 31.54% to investors over the past 6 months.

On January 26, CVRx, Inc. (NASDAQ:CVRX)  reported earnings for the fiscal fourth quarter of 2022. The company generated a revenue of $7.18 million, up 96.17% year over year, and outperformed Wall Street estimates by $198,800.

At the end of Q4 2022, CVRx, Inc. (NASDAQ:CVRX) was held by 10 hedge funds. These funds held collective stakes worth $40.9 million in the company, up from $25.5 million in the previous quarter with 8 positions. The hedge fund sentiment for the stock is positive.

As of December 31, Soleus Capital is the top investor in CVRx, Inc. (NASDAQ:CVRX) and has disclosed a position worth $18.6 million in the company. CVRx, Inc. (NASDAQ:CVRX) is ranked fourth on our list of the top high growth micro-cap stocks to buy according to hedge funds.